Late pregnancy associated plasma protein A levels decrease in preterm labor

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue 7, 2011, Pages 923-927

  Atis, Alev ^a,c   Tandogan, Turkan ^a   Aydin, Yavuz ^b   Sen, Cihat ^b   Turgay, Fatma ^a   Eren, Nezaket ^a   Goker, Nimet ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Atakent Mah ^*  (Turkey)

Author keywords

late pregnancy; PAPP A; preterm birth; threatened preterm labor

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FETUS WEIGHT; GESTATIONAL AGE; HUMAN; MATERNAL BLOOD; PREDICTIVE VALUE; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; THIRD TRIMESTER PREGNANCY;

ADULT; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 79958022462     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2010.531320     Document Type: Article

References (34)

1. Smith R. Parturition. N Engl J Med 2007;356:271-283. (Pubitemid 46143230)
2. Gotsch F, Gotsch F, Romero R, Erez O, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, Hassan S, Yeo L. The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J Matern Fetal Neonatal Med 2009;22 (Suppl 2):5-23.
3. Romero R, Sepulveda W, Baumann P, Yoon BH, Brandt F, .Gomez R, Mazor M, Sorokin Y, Cotton D. The preterm labor syndrome: biochemical, cytologic, immunologic, pathologic, microbiologic, and clinical evidence that preterm labor is a heterogeneous disease. Am J Obstet Gynecol 1993;168:288.
4. Sayres WG. Preterm labor. Am Fam Physician 2010;81:477-484.
5. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371;75-84. Review .
6. Parant O, Maillard F, Tsatsaris V, Delattre M, Subtil D, Goffinet F; EVAPRIMA Group. Management of threatened preterm delivery in France: a national practice survey (the EVAPRIMA study). BJOG 2008;115:1538-1546.
7. Lin TM, Galbert SP, Kiefer D, Spellacy WN, Gall S. Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 1974;118:223-236.
8. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR 3rd, Conover CA. The insulinlike growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999;96:3149-3153. (Pubitemid 29148859)
9. Sun IY, Overgaard MT, Oxvig C, Giudice LC. Pregnancyassociated plasma protein A proteolytic activity is associated with the human placental trophoblast cell membrane. J Clin Endocrinol Metab 2002;87:5235-5240. (Pubitemid 35316369)
10. Folkersen J, Grudzinskas JG, Hindersson P, Teisner B, Westergaard JG. Pregnancy-associated plasma protein A: circulating levels during normal pregnancy. Am J Obstet Gynecol 1981;139:910-914. (Pubitemid 11070296)
11. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 1993;268:12243-12246. (Pubitemid 23182369)
12. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, Gleich GJ, Sottrup-Jensen L, Conover CA, Oxvig C. Expression of recombinant human pregnancyassociated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 2000;275:31128-31133.
13. Kristensen T, Oxvig C, Sand O, Moller NP, Sottrup-Jensen L. Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry 1994;33:1592-1598. (Pubitemid 24093710)
14. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free b-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008;31:618-624.
15. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free b-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13:231-237. (Pubitemid 29248329)
16. Marttala J, Peuhkurinen S, Laitinen P, Gissler M, Nieminen P, Ryynanen M. Low maternal PAPP-A is associated with small-for-gestational age newborns and stillbirths. Acta Obstet Gynecol Scand 2010;89:1226-1228.
17. Tul N, Pusenjak S, Osredkar J, Spencer K, Novak-Antolic Z. Predicting complications of pregnancy with first-trimester maternal serum free-b-hCG, PAPP-A and inhibin-A. Prenat Diagn 2003; 23: 990-996. (Pubitemid 38004790)
18. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Füchtbauer EM, Oxvig C, van Deursen J. Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 2004;131:1187-1194. (Pubitemid 38380471)
19. Resch ZT, Chen BK, Bale LK, Oxvig C,Overgaard MT, Conover Ca. Pregnancy-associated plasma protein-A gene expression as a target of inflammatory cytokines. Endocrinology 2004;145:1124-1129. (Pubitemid 38280991)
20. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585-591. (Pubitemid 23069118)
21. Brar HS, Medearis AL, De Vore GR, Platt LD. Maternal and fetal blood flow velocity waveforms in patients with preterm labor: relationship to outcome. Am J Obstet Gynecol 1989; 161:1519-1522. (Pubitemid 20024022)
22. Grisaru-Granovsky S, Halevy T, Planer D, Elstein D, Eidelman A, Samueloff A. PAPP-A levels as an early marker of idiopathic preterm birth: a pilot study. J Perinatol 2007;27:681-686. (Pubitemid 350020347)
23. Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA 2000;284:843-849.
24. Mikkola K, Ritari N, Tommiska V, Salokorpi T, Lehtonen L, Tammela O, Pääkkönen L, Olsen P, Korkman M, Fellman V. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997. Pediatrics 2005;116:1391-1400. (Pubitemid 46056487)
25. Mathews TJ, Menacker F, MacDorman MF. Infant mortality statistics from the 2002 period linkedbirth/infant death data set. Natl Vital Stat Rep 2004;53:1-30.
26. Honest H, Forbes CA, Durée KH, Norman G, Duffy SB, Tsourapas A, Roberts TE, Barton PM, Jowett SM, Hyde CJ, et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2009;13:1-627.
27. Tsourapas A, Roberts TE, Barton PM, Honest H, Forbes C, Hyde CJ, Khan KS. An economic evaluation of alternative test-intervention strategies to prevent spontaneous predelivery based on maternal plasma urocortin. Acta Obstet Gynecol Scand 2009;88:1319-1330.
28. ColemanMA, France JT, Schellenberg JC, Ananiev V, Townend K, Keelan JA, Groome NP, McCowan LM. Corticotropinreleasing hormone, corticotropin-releasing hormone-binding protein, and activin A in maternal serum: prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor. Am J Obstet Gynecol 2000;183:643-648.
29. Florio P, Linton EA, Torricelli M, Faldini E, Reis FM, Imperatore A, Calonaci G, Picciolini E, Petraglia F. Prediction of preterm delivery based on maternal plasma urocortin. J Clin Endocrinol Metab 2007;92:4734-4737. (Pubitemid 350223452)
30. McPheeters ML, Miller WC, Hartmann KE, Savitz DA, Kaufman JS, Garrett JM, Thorp JM. The epidemiology of threatened preterm labor: a prospective cohort study. Am J Obstet Gynecol 2005;192:1325-1329.
31. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002;22:778-782.
32. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000;107:1265-1270.
33. Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beekhuis JR, de Wolf BT, Mantingh A. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 1998;18:147-152. (Pubitemid 28077408)
34. Ozer KT, Kavak ZN, Gö kaslan H, Elter K, Pekin T. Predictive power of maternal serum and amniotic fluid CRP and PAPP-A concentrations at the time of genetic amniocentesis for the preterm delivery. Eur J Obstet Gynecol Reprod Biol 2005;122:187-190. (Pubitemid 41428154)